0 items USD 0.00Search
- Did you mean
- here+
Your search for "HER2%2B" gave back 967 results.
HR+/HER2-Breast Cancer The “HR+HER2- Breast Cancer Industry Forecast” looks at past sales and reviews total world HR+HER2- Breast Cancer sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “HER-2 Negative Breast Cancer Industry Forecast” looks at past sales and reviews total world HER-2 Negative Breast Cancer sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. Market...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
According to our (Global Info Research) latest study, the global HER2 Testing market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global HER2 Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the HER2 Targeted Therapy market will undergo major changes...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
The global HER2 Targeted Therapy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The “Targeted Drug HER2 Inhibitors for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drug HER2 Inhibitors for NSCLC...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “HER-2 Targeted Drugs for Breast Cancer Industry Forecast” looks at past sales and reviews total world HER-2 Targeted Drugs for Breast Cancer...
Catalog:
LPI
March 2023
Price: USD 3,660.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Drugs for HR+/HER2- Advanced Breast Cancer market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during...
Catalog:
GIR
February 2023
Price: USD 4,480.00
These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. The “Mono...
Catalog:
LPI
February 2023
Price: USD 3,660.00
HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Drugs for HR+/HER2- Advanced Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
